Table 2. Results of logistic regression analysis of baseline characteristics associated with the risk of immunological non-response (an increase of <50 cells/μl).
| Characteristics | Risk of immunological non-response at 12 months | ||
|---|---|---|---|
| OR (95% CI) | p value | ||
| Gender | Female | 1 | |
| Male | 2.02 (1.26, 3.24) | 0.004 | |
| Age (years) | ≤45 | 1 | |
| >45 | 1.34 (0.81, 2.22) | 0.261 | |
| WHO clinical stage | I | 1 | |
| II | 1.07 (0.52, 2.17) | 0.859 | |
| III | 1.21 (0.64, 2.31) | 0.554 | |
| IV | 1.23 (0.47, 3.22) | 0.678 | |
| Baseline CD4 count | ≤200 | 1 | |
| 201–350 | 1.90 (1.14, 3.18) | 0.014 | |
| >350 | 5.53 (2.77, 11.04) | 0.000 | |
| Weight (kg) | <40 | 1 | |
| 40–60 | 1.05 (0.50, 2.17) | 0.901 | |
| >60 | 1.26 (0.45, 3.55) | 0.668 | |